Alector Stock Quote ALEC - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

6.37

Bid

6.38

Ask

6.56

Volume

0.00 Day's Range 0.00

3.66 52 Week Range 9.065

Market Cap

613.97M

Previous Close

6.37

Open

Last Trade

6.37

Last Trade Time

08:00:00

Financial Volume

VWAP

Average Volume (3m)

662,402

Shares Outstanding

96,384,562

Dividend Yield

PE Ratio

-4.71

Earnings Per Share (EPS)

-1.35

Revenue

97.06M

Net Profit

-130.39M

Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to... Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline product inlcude AL001, AL002, AL003, and AL101. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.alector.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Alector Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ALEC. The last closing price for Alector was $6.37. Over the last year, Alector shares have traded in a share price range of $ 3.66 to $ 9.065.

Alector currently has 96,384,562 shares outstanding. The market capitalization of Alector is $613.97 million. Alector has a price to earnings ratio (PE ratio) of -4.71.

Overall Flow

Bullish

Net Premium

28k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform

SOUTH SAN FRANSISCO, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced management will...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.55	9.45017182131	5.82	6.43	5.7021	933618	5.95697973	CS
4	1.82	40	4.55	6.43	4.16	646552	5.2031477	CS
12	1.18	22.7360308285	5.19	6.43	4.11	662402	5.01216181	CS
26	0.31	5.11551155116	6.06	7.5773	4.11	664844	5.62572357	CS
52	-0.31	-4.64071856287	6.68	9.065	3.66	676572	5.98911081	CS
156	-25.39	-79.943324937	31.76	35.14	3.66	630852	10.9054693	CS
260	-12.63	-66.4736842105	19	45	3.66	663326	15.6598285	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.162 (0.00%)	5.58M
AADRAdvisorShares Dorsey Wright ADR ETF	$ 62.91 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.51 (0.00%)	4
AACIArmada Acquisition Corporation I	$ 11.35 (0.00%)	71
AACGATA Creativity Global	$ 0.65 (0.00%)	108
AAGRAfrican Agriculture Holdings Inc	$ 0.162 (0.00%)	5.58M
AADRAdvisorShares Dorsey Wright ADR ETF	$ 62.91 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.51 (0.00%)	4
AACIArmada Acquisition Corporation I	$ 11.35 (0.00%)	71
AACGATA Creativity Global	$ 0.65 (0.00%)	108
WRNTWarrantee Inc	$ 0.291 (0.00%)	47.51M
ATPCAgape ATP Corporation	$ 0.143 (0.00%)	41.4M
GPAKGamer Pakistan Inc	$ 0.1661 (0.00%)	37.73M
WBUYWeBuy Global Ltd	$ 0.1609 (0.00%)	19.31M
ADILAdial Pharmaceuticals Inc	$ 1.06 (0.00%)	16.89M